Anna Amiss, PhD, is a Senior Preclinical Scientist currently managing the Mater Inflammatory Bowel Disease (IBD) Biobank and conducting scientific analysis of samples at the Mater IBD Clinical Trials Unit. Additionally, they oversee the IBD Research Group at the Translational Research Institute. Anna's PhD research focused on developing strategies to combat multi-drug resistant bacterial infections, particularly through the use of peptides. Previously, Anna served as a Research Assistant at The University of Queensland, where they contributed to research on cholesterol-regulatory proteins, and they have held positions as a Senior Research Assistant and Project Manager at Mater Research.
This person is not in any teams
This person is not in any offices